TAK-573
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-573, covering 2026-01-14 to 2026-01-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) [Phase 1]